Nutrition and exercise study for adults hospitalized with acute lymphoblastic leukemia
Tests nutrition and exercise programs in adults with B-cell acute lymphoblastic leukemia during hospital treatment.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 12 May 2025
- Expected to end
- 6 Nov 2027
- Type of study
- Interventional
- Treatments tested
- Nutrition Intervention
- Exercise intervention
- Record updated
- 19 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed Philadelphia Chromosome negative B-cell acute lymphoblastic leukemia who are getting intensive induction chemotherapy.
- Age
- 18 to 50 years
- Sex
- All sexes can join.
- Disease stage
- New diagnosis of Philadelphia Chromosome negative B-ALL.
- Earlier treatment
- The person is receiving intensive pediatric-inspired induction chemotherapy.
- Biomarker or test result
- Philadelphia Chromosome negative.
Main reasons for not taking part
- BMI of 18.5 kg/m2 or lower at diagnosis
- Unable to follow both the diet and the exercise plan, as judged by the research or treatment team
- Pregnant
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- New Diagnosis of Philadelphia Chromosome Negative B-ALL
- Receiving intensive pediatric-inspired induction chemotherapy
Who cannot take part
- BMI ≤18.5 kg/m2 at time of diagnosis
- Unable to comply with both the recommended diet and exercise regimen as deemed by the research or treatment team
- Pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of Chicago Medicine-Comprehensive Cancer CenterChicago, United StatesContact: Clinical Trials intakeTaking people
About the trial
What the trial wants to find out
This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy.
Read full original descriptionShow less
Participants will take part in 2 different interventions:
* Nutrition Intervention * Physical Exercise Intervention
All subjects will be provided with a wearable electronic activity monitor (FitBit®) to assist in recording activity levels in minutes of activity.
The group in the trial
- Nutrition and Exercise interventionsTreatment being tested
Participants will receive an exercise and nutrition (diet) intervention while hospitalized for routine treatment for their ALL.
Treatment: Nutrition Intervention and Exercise intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Nutrition and Exercise to Optimize Muscle and Adiposity in Adults With ALL: NEOMA ALL Trial
- Plain-language title
- Nutrition and exercise study for adults hospitalized with acute lymphoblastic leukemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06785324, who can take part
- Record updated
- 19 June 2025